THE CHIEF
COMPLAINT

Disease States

Lupus Flare

Back To Contents
  • Known SLE with new or worsening symptoms: organ-threatening disease, or infection / thrombosis / another cause?

The Algorithm...

01 Assess Severity

  • Assess ABCs, vital signs, oxygenation, perfusion, and mentation. Treat shock, respiratory failure, seizures, or significant bleeding.

02 Organ Involvement?

  • Assess kidney, neurologic, pulmonary, cardiac, hematologic, and abdominal symptoms. Rash / joint pain does not exclude concurrent organ involvement.

03 Flare Or Mimic? / Workup

  • Assess infection, thrombosis, medication effects, and recent steroid changes.
  • CBC / CMP / urine studies; activity markers and additional testing according to the presentation. See Workup.

04 Treat

  • Treat the identified emergency; involve rheumatology and the affected organ service.
  • Suspected infection requires appropriate antimicrobials; organ-threatening lupus may require urgent steroids while that evaluation proceeds.

05 Reassess / Destination

  • Discharge: Mild symptoms, reassuring evaluation, reliable follow-up.
  • Monitored Admission: Organ involvement or unresolved concern requiring inpatient evaluation.
  • ICU Admission: Respiratory failure, shock, major bleeding, or other critical organ dysfunction.

Initial Assessment

  • Flare: New or worsening immune-mediated SLE activity. Rash, oral ulcers, inflammatory joint symptoms, and fatigue may be mild; fatigue / generalized pain alone does not establish active inflammation.
  • Review prior nephritis, CNS disease, pulmonary hemorrhage, myocarditis, cytopenias, and antiphospholipid syndrome (APS) / thrombosis.
  • Review prednisone dose, immunosuppressants, adherence, recent taper / interruption, and infection symptoms. Compare current findings with the patient's baseline. ACR 2025.

Organ-Threatening Disease?

Kidney — Nephritis

  • Clues: Rising creatinine, proteinuria, glomerular hematuria / RBC casts, new hypertension, or edema. Nephritis may be present without prominent symptoms.
  • Obtain creatinine, UA / microscopy, urine protein–creatinine ratio, and BP; compare with prior results.
  • Proteinuria >0.5 g/g or otherwise unexplained renal dysfunction warrants nephrology / rheumatology assessment for biopsy. This is a biopsy threshold—not an automatic ED procedure. ACR Nephritis.

Neurologic

  • Clues: Seizure, confusion / psychosis, focal deficit, myelitis, significant new neuropathy, or severe headache / meningitic symptoms.
  • Assess stroke, infection, metabolic disturbance, and medication effects before attributing symptoms to lupus. Consider CT / MRI, LP, EEG, and neurology consultation according to the syndrome. ACR 2025.

Pulmonary

  • Hypoxemia + bilateral infiltrates + falling hemoglobin: Suspect diffuse alveolar hemorrhage; hemoptysis may be absent.
  • Obtain chest imaging and serial hemoglobin; involve pulmonary / critical care early. Consider bronchoscopy while assessing infection, edema, pneumonitis, and PE. Virdi 2012.

Cardiac

  • Clues: Chest pain, new heart failure / arrhythmia, or hypotension; consider myocarditis, pericarditis / tamponade, and ACS.
  • Obtain ECG / troponin; consider POCUS / echocardiography and monitoring. Treat the cardiac emergency rather than assuming all chest pain is lupus serositis. ACR 2025.

Hematologic

  • Clues: Rapid hemoglobin fall, hemolysis, substantial thrombocytopenia, bleeding, or pancytopenia. Platelets <30,000/µL warrant prompt treatment assessment; bleeding and organ dysfunction determine urgency.
  • Thrombocytopenia + hemolysis / schistocytes: Consider thrombotic microangiopathy (TMA / TTP). Obtain smear, reticulocytes, LDH, bilirubin, haptoglobin, DAT, and coagulation studies; urgent hematology involvement when suspected. ACR 2025.

GI / Vascular

  • Severe abdominal pain / peritoneal findings: Assess mesenteric vasculitis, ischemia, and other surgical causes; urgent imaging / surgical assessment as indicated.
  • Stroke / PE / DVT / arterial occlusion: Consider APS and follow the corresponding emergency pathway. Thrombosis is not automatically an inflammatory flare. ACR 2025.

Flare Or Infection? / Workup

Infection / Other Mimics

  • Fever + immunosuppression: Assess an infectious source; obtain cultures / imaging and start antimicrobials when indicated. Infection and flare can coexist.
  • Consider medication toxicity, steroid withdrawal / adrenal insufficiency, thrombosis, and unrelated emergencies. ACR 2025.

Laboratory Assessment

  • Organ Screen: Consider CBC / differential, CMP / creatinine, UA / microscopy, and urine protein–creatinine ratio. Compare with baseline.
  • Activity Markers: ESR / CRP, C3 / C4 ± anti-dsDNA. Falling complement and rising anti-dsDNA support activity; ANA does not measure current flare activity.
  • Infection Clues: Marked CRP elevation / neutrophilia may favor infection. ESR:CRP ratio or procalcitonin may help selectively, but none reliably separates infection from flare. Littlejohn 2018 · Abdel-Magied 2024.
  • Additional Testing: Cultures / lactate, pregnancy testing, CK, and symptom-directed imaging as indicated. Do not delay urgent care for complement or antibody results.

Treatment / Consultation

Infection Versus Organ-Threatening Flare

  • Assess infection before escalating steroids for undifferentiated fever. When organ-threatening lupus is likely, antimicrobials and urgent immunosuppression may need to proceed together.
  • Involve rheumatology plus the affected organ service early. ACR conditionally supports methylprednisolone 250–1,000 mg IV daily for 1–3 days for organ- or life-threatening flare, followed by specialist-directed taper / additional therapy. ACR 2025.
  • Suspected nephritis: Coordinate treatment promptly; necessary steroids may begin while biopsy is arranged. ACR Nephritis.

Mild Symptoms

  • Symptom control, medication review, and prompt rheumatology follow-up when the evaluation is reassuring.
  • Assess renal function, bleeding risk, anticoagulation, and pregnancy before NSAIDs. Coordinate changes to long-term immunosuppression with the treating clinician.

Reassessment / Disposition

Discharge

  • Mild symptoms, stable vital signs, and reassuring renal / urine, hematologic, neurologic, and cardiopulmonary assessment.
  • Serious infection / thrombosis reasonably excluded for the presentation; oral treatment, medication access, and timely follow-up established.
  • Return precautions for dyspnea, confusion, reduced urine output, bleeding, severe pain, or worsening fever.

Monitored Admission

  • Suspected organ involvement, important cytopenia / serositis, new oxygen need, or persistent symptoms requiring inpatient testing / treatment.
  • Serious flare versus infection cannot be managed safely through an outpatient pathway.

ICU Admission

  • Alveolar hemorrhage with respiratory compromise, tamponade, unstable myocarditis / arrhythmia, shock, uncontrolled seizures, or severe encephalopathy.
  • Major bleeding, TMA / catastrophic APS with organ dysfunction, or another critical illness requiring intensive support.

In The Pit

  • Unstable: Treat the organ emergency; rheumatology plus the relevant service early.
  • Fever / Immunosuppression: Assess infection—not an automatic steroid escalation.
  • Kidney: Check creatinine and urine; nephritis may be clinically quiet.
  • Lungs: Hypoxemia + infiltrates + falling hemoglobin → urgent hemorrhage assessment, even without hemoptysis.
  • Steroids: Organ-threatening disease may require treatment before the infectious evaluation is complete.
  • Discharge: Mild symptoms only after reassuring organ assessment and a reliable plan.

Must-Read References

View Full References

Additional Cited Evidence

  • Littlejohn 2018 — ESR:CRP in febrile SLE; small retrospective study.
  • Abdel-Magied 2024 — Infection biomarkers; small study, not a standalone decision rule.
  • Virdi 2012 — Alveolar hemorrhage case report and review; diagnostic pitfalls.

Privacy & analytics choices